Govt Job: For M.Pharm as Junior Associate at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab, and the distinguished medical educators of the then combined state of Punjab, who, supported by the first Prime Minister of India, Pt. Jawahar Lal Nehru, considered the institutions of scientific knowledge as temples of learning and places of pilgrimage.

Post: Junior Materiovigilance Associate

Applications are invited on a plain paper for the contractual post of Junior Materiovigilance Associate under NCC-PvPI, IPC Regional Center, Department of Pharmacology, Chandigarh-160012.

Qualification : Graduation in Biomedical Engineering / Clinical Engineering or Master’s in Pharmacy

Desirable Experience: Good knowledge of Computers

Age: Not exceeding 28 years

Pay Scale: Rs. 26,250/- per month

Nature of Job: Purely Contractual (As per GeM contract)

Interested candidates fulfilling the above conditions are required to submit their bio-data and necessary testimonials/ certificates by 18th December 2022 through email at recruitmentmanpowereplpgimer@gmail.com

The short-listed candidates will be intimated through email to attend the personal or virtual interview.

Related Posts

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March